|
HNRNPH3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.224330E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.041900E-03 |
| Normal-vs-Stage2 |
5.556100E-03 |
| Normal-vs-Stage3 |
1.639290E-03 |
| Normal-vs-Stage4 |
4.150300E-02 |
| Stage1-vs-Stage2 |
8.601400E-01 |
| Stage1-vs-Stage3 |
7.314600E-01 |
| Stage1-vs-Stage4 |
9.494400E-01 |
| Stage2-vs-Stage3 |
9.025000E-01 |
| Stage2-vs-Stage4 |
9.485800E-01 |
| Stage3-vs-Stage4 |
8.725800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.964260E-03 |
| Normal-vs-AfricanAmerican |
4.216000E-03 |
| Normal-vs-Asian |
1.710610E-01 |
| Caucasian-vs-AfricanAmerican |
9.727000E-01 |
| Caucasian-vs-Asian |
9.156000E-01 |
| AfricanAmerican-vs-Asian |
9.038400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.362360E-04 |
| Normal-vs-Female |
1.074590E-01 |
| Male-vs-Female |
2.749600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.158800E-03 |
| Normal-vs-Extreme_Weight |
3.227000E-04 |
| Normal-vs-Obese |
4.329500E-02 |
| Normal-vs-Extreme_Obese |
3.241600E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.769400E-01 |
| Normal_Weight-vs-Obese |
1.580240E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.325200E-01 |
| Extreme_Weight-vs-Obese |
5.696000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.238400E-01 |
| Obese-vs-Extreme_Obese |
8.578100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.081000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.982000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.829000E-04 |
| Normal-vs-Age(81-100Yrs) |
5.924600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.076400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.448100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.840000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.914630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.460800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.963400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.356040E-02 |
| Normal-VS-Type2 PRCC |
1.02070000229659E-08 |
| Normal-VS-KIRP CIMP |
5.829400E-01 |
| Normal-VS-Unclassified PRCC |
1.423620E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.59390000046223E-07 |
| Type1 PRCC-VS-KIRP CIMP |
3.951800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.102800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.74393999999856E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
7.300300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.467600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.62409999998814E-06 |
| Normal-vs-N1 |
2.893600E-01 |
| Normal-vs-N2 |
7.304100E-02 |
| N0-vs-N1 |
4.718400E-03 |
| N0-vs-N2 |
9.841800E-01 |
| N1-vs-N2 |
2.664600E-01 |
|
|
